Apellis Pharmaceuticals Option Alert: Nov 17 $55 Calls at the Ask: 1186 @ $4.0 vs 238 OI; Earnings 11/6 After Close [est] Ref=$49.61
Portfolio Pulse from Charles Gross
Apellis Pharmaceuticals has seen a significant increase in call options for November 17 at $55, with 1186 contracts at $4.0, compared to an open interest of 238. The company is expected to release its earnings report on November 6.
September 20, 2023 | 4:27 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Increased call options for Apellis Pharmaceuticals suggest bullish sentiment among investors ahead of the company's earnings report.
The significant increase in call options indicates that investors are expecting the stock price of Apellis Pharmaceuticals to rise. This bullish sentiment is likely due to the upcoming earnings report, which investors may expect to be positive.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100